This country profile provides an overview of Gambia’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
100%
Intestinal worms
44%
Bilharzia
85%
River blindness
N/A
0.11 million people received treatment in Gambia in 2017 0.05 million people did not receive treatment in Gambia in 2017

Priorities for progress in Gambia

  • Gambia is encouraged to work to build a strong preventive chemotherapy programme for bilharzia and intestinal worms, with systematic annual high-coverage implementation of all components, in all risk groups, as recommended by WHO.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Gambia does not require mass treatment for elephantiasis.

Blinding trachoma

Gambia does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage decreased from 47% in 2016 to 44% in 2017.

Pre-sch and school-aged children needing treatment
0.08m
Pre-school and school-aged children receiving treatment
0.04m

Bilharzia

Treatment coverage was not reported in 2016 and 85% in 2017.

School-aged children needing treatment
0.09m
School-aged children receiving treatment
0.08m

River blindness

Gambia does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Gambia.